\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Stock Quote

NASDAQCRDF
$10.11
NASDAQCRDF
Open
$10.25
Change
-$0.17 (-1.65%)
Day's Range
$9.60 - $10.47
52-Week Range
$0.71 - $25.50
Volume
922.4K
Market Cap
$357.1M